BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20081321)

  • 21. Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor.
    Korn E; Van Hoff J; Buckley P; Daughaday WH; Carpenter TO
    Med Pediatr Oncol; 1995 Jun; 24(6):392-6. PubMed ID: 7715546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia.
    Zapf J
    Horm Res; 1994; 42(1-2):20-6. PubMed ID: 7525443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of streptozotocin-induced diabetes mellitus on growth and hepatic insulin-like growth factor I gene expression in the rat.
    Yang H; Scheff AJ; Schalch DS
    Metabolism; 1990 Mar; 39(3):295-301. PubMed ID: 2407928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
    Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acinar cell carcinoma of the pancreas associated with hypoglycemia: involvement of "big" insulin-like growth factor-II.
    Mizuta Y; Isomoto H; Futuki Y; Ehara N; Takeshima F; Omagari K; Murase K; Yakata Y; Senjyu M; Masuda J; Ikuno N; Haraguchi M; Iwasaki K; Shimokawa I; Kohno S
    J Gastroenterol; 1998 Oct; 33(5):761-5. PubMed ID: 9773947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
    Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
    Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
    Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins, and IGF gene expression in the offspring of ethanol-fed rats.
    Singh SP; Srivenugopal KS; Ehmann S; Yuan XH; Snyder AK
    J Lab Clin Med; 1994 Aug; 124(2):183-92. PubMed ID: 7519654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solitary fibrous tumor of the uterus producing high-molecular-weight insulin-like growth factor II and associated with hypoglycemia.
    Wakami K; Tateyama H; Kawashima H; Matsuno T; Kamiya Y; Jin-No Y; Kimura G; Eimoto T
    Int J Gynecol Pathol; 2005 Jan; 24(1):79-84. PubMed ID: 15626921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid.
    Lowe WL; Roberts CT; LeRoith D; Rojeski MT; Merimee TJ; Fui ST; Keen H; Arnold D; Mersey J; Gluzman S
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1153-9. PubMed ID: 2584352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor II-producing intra-abdominal hemangiopericytoma associated with hypoglycemia.
    Matsuda S; Usui M; Sakurai H; Suzuki H; Ogura Y; Shiraishi T
    J Gastroenterol; 2001 Dec; 36(12):851-5. PubMed ID: 11777215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe hypoglycemia with "Big"-IGF-2 oversecretion by a giant phyllode tumor of the breast: a rare case of non-islet cell tumor-induced hypoglycemia (NICTH).
    Renard E; Langbour-Remy C; Klein M; Le Bouc Y; Weryha G; Cuny T
    Ann Endocrinol (Paris); 2012 Nov; 73(5):488-91. PubMed ID: 22867750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia.
    Teale JD; Marks V
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):87-98. PubMed ID: 2205424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury.
    Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Oka T; Takenaka A; Takahashi S; Noguchi T
    JPEN J Parenter Enteral Nutr; 1997; 21(2):55-62. PubMed ID: 9084006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors.
    Yonei Y; Tanaka M; Ozawa Y; Miyazaki K; Tsukada N; Inada S; Inagaki Y; Miyamoto K; Suzuki O; Okawa H
    Liver; 1992 Apr; 12(2):90-3. PubMed ID: 1320177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth.
    Wolf E; Kramer R; Blum WF; Föll J; Brem G
    Endocrinology; 1994 Nov; 135(5):1877-86. PubMed ID: 7525257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.